Covid-19: Oxford vaccine may get nod in a few days

India is likely to see the Oxford-AstraZeneca vaccine approved for emergency use in the next few days, as “satisfactory” appears to be the revised data submitted by the Serum Institute of India (SII), top government sources said.

Once the data assessment is complete, the regulator does not wait for the vaccine to be approved by the Regulatory Agency for Medicines and Healthcare Products of the UK (MHRA).

Regulatory decisions will be taken independently. The business has given the same details here from clinical trials in the UK and Brazil, and there are rolling reports. It also appears that the revised knowledge shared by the Serum Institute is satisfactory so it is optimistic that the vaccine will be approved in a day or two based on regulatory evaluation.


However, as MHRA is already reviewing the data for the vaccine produced by Oxford University and pharmaceutical major AstraZeneca, it is very likely that the United Kingdom may also issue emergency use authorization in the meantime.

A PTI study said the CEO of the drug major, Pascal Soriot, announced that the Covishield vaccine had achieved a “winning formula” for effectiveness. Soriot’s remarks were recorded in a Sunday Times newspaper interview. He added that he expects trials would indicate that his company has achieved a vaccine efficacy equal to 95 percent of Pfizer-BioNTech and 94.5 percent of Moderna.

For more information-
Read from the source: